What the WikiLeaks reveal

TPP requires member states to dilute their stand on labour, environmental and patent standards to favour MNCs Release date and topic | June 10, 2015, annex on transparency for pharma products and medical devices Document date | January 20, 2015 Details | Seeks to regulate state schemes for medicines and medical devices; forces healthcare authorities to give big pharma more information about national decisions on public access to medicine; grants firms greater powers to challenge decisions Release date and topic | March 25, 2015, Investment Chapter Document date | January 20, 2015 Details | Foreign firms can sue states and obtain taxpayer compensation for "expected future profits" if government policies change Release date and topic | January 15, 2014, consolidated environment chapter Document date | November 19-24, 2013 Details | No mandated clauses or meaningful enforcement measures; no penalties, no proposed criminal sanctions or a binding dispute settlement mechanism; main area of contention is role of TPP vis a vis multilateral agreements Release date and topic | October 16, 2014, updated chapter on Intellectual Property Document date | October 16, 2014 Details | Industry-favouring measures on pharmaceuticals and patents likely to curb access to cancer drugs, etc; weaker requirements for patenting plant genes. This would impact small farmers and boost control by large agri MNCs such as Monsanto Release date and topic | November 13, 2013, chapter on Intellectual Property Document date | 26-30 August 2013 Details | Proposals to increase term of patents, including medical patents, beyond 20 years; lower global standards for patentability; aggressive measures to prevent hackers breaking copyright protection; repressive Internet censorship